Showing 8,761 - 8,780 results of 18,571 for search 'significantly ((((mean decrease) OR (((we decrease) OR (a decrease))))) OR (greater decrease))', query time: 0.65s Refine Results
  1. 8761

    Table1_Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.DOCX by Luyang Su (20411552)

    Published 2025
    “…Unforeseen significant AEs such as unintended pregnancy (n = 623; ROR, 6.65; ROR025, 6.1; χ<sup>2</sup>, 2,482.38; PRR, 6.41; EBGM, 5.69; EBGM05, 5.29), bone pain (n = 35; ROR, 13.78; ROR025, 9.4; χ<sup>2</sup>, 311.2; PRR, 13.75; EBGM, 10.59; EBGM05, 7.69), gait disturbance (n = 34; ROR, 2.82; ROR025, 1.99; χ<sup>2</sup>, 37.31; PRR, 2.88; EBGM, 2.7; EBGM05, 2.02), dental caries (n = 15; ROR, 23.16; ROR025, 12.32; χ<sup>2</sup>, 204.26; PRR, 23.14; EBGM, 15.23; EBGM05, 8.98), decrease in blood pressure (n = 15; ROR, 3.88; ROR025, 2.29; χ<sup>2</sup>, 29.35; PRR, 3.88; EBGM, 3.63; EBGM05, 2.33), and osteonecrosis (n = 9; ROR, 23.44; ROR025, 10.36; χ<sup>2</sup>, 123.67; PRR, 23.43; EBGM, 15.35; EBGM05, 7.75) were identified as AEs that were not previously outlined in the prescribing information of the medication.…”
  2. 8762

    Table1_Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.DOCX by Luyang Su (20411552)

    Published 2024
    “…Unforeseen significant AEs such as unintended pregnancy (n = 623; ROR, 6.65; ROR025, 6.1; χ<sup>2</sup>, 2,482.38; PRR, 6.41; EBGM, 5.69; EBGM05, 5.29), bone pain (n = 35; ROR, 13.78; ROR025, 9.4; χ<sup>2</sup>, 311.2; PRR, 13.75; EBGM, 10.59; EBGM05, 7.69), gait disturbance (n = 34; ROR, 2.82; ROR025, 1.99; χ<sup>2</sup>, 37.31; PRR, 2.88; EBGM, 2.7; EBGM05, 2.02), dental caries (n = 15; ROR, 23.16; ROR025, 12.32; χ<sup>2</sup>, 204.26; PRR, 23.14; EBGM, 15.23; EBGM05, 8.98), decrease in blood pressure (n = 15; ROR, 3.88; ROR025, 2.29; χ<sup>2</sup>, 29.35; PRR, 3.88; EBGM, 3.63; EBGM05, 2.33), and osteonecrosis (n = 9; ROR, 23.44; ROR025, 10.36; χ<sup>2</sup>, 123.67; PRR, 23.43; EBGM, 15.35; EBGM05, 7.75) were identified as AEs that were not previously outlined in the prescribing information of the medication.…”
  3. 8763

    Raw data associated with this manuscript. by Alicer K. Andrew (12269646)

    Published 2025
    “…This work utilizes experimental murine models of PM (EPM) and CM (ECM) to explore the impact of anticoagulant treatment and tissue-specific or global reduction in TF expression on disease outcomes. In EPM, we show that treatment of wild-type mice with dalteparin, an anticoagulant class that is safe to use in humans during pregnancy, prevented malaria-induced pregnancy loss, significantly improved embryo viability, and decreased placental fibrin deposition at midgestation. …”
  4. 8764

    Table 1_Deep brain stimulation for obsessive compulsive disorder leads to symptom changes of comorbid irritable bowel syndrome.docx by Mohamed A. Abdelnaim (16976001)

    Published 2025
    “…The mean Y-BOCS decreased from 31.11 at baseline to 16.50 at the last follow-up. …”
  5. 8765

    Data Sheet 1_Understanding mechanistic relationships between IgG titers and Fc effector functions: a computational framework to assess polyfunctionality.docx by Suzanne K. Shoffner-Beck (22253548)

    Published 2025
    “…Surprisingly, simulated boosting of IgG3 alone had the potential to significantly decrease ADCP (p<0.00001), though it would increase ADCC responses. …”
  6. 8766

    Table 1_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …”
  7. 8767

    Table 3_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …”
  8. 8768

    Table 2_Prevalence and duration of clinical symptoms of pediatric long COVID: findings from a one-year prospective study.docx by Vita Perestiuk (22290208)

    Published 2025
    “…Younger age was associated with insomnia (OR = 0.49, p = 0.018). Female sex was significantly associated with a greater likelihood of lack of energy (OR = 2.55, p = 0.048). …”
  9. 8769

    Table 1_Association between serum albumin and severe impairment of activities of daily living in patients with stroke: a cross-sectional study.docx by Ranran Bi (20505614)

    Published 2025
    “…After adjusting for confounding factors, the multivariate analysis revealed a 7% decrease in severe impairment of ADL after stroke for every unit (g/L) increase in serum albumin levels. …”
  10. 8770

    Renamed 05c60. by Hongjun Sun (12554742)

    Published 2025
    “…The study reveals three key findings. (1) Contribution levels of China’s eight comprehensive economic zones to national standard development have significantly increased. The Northern Coastal comprehensive economic zone has the highest contribution levels, followed by the Eastern and Southern Coastal zones, whereas the Northwestern and Northeastern zones have lower contribution levels. (2) The overall regional disparity in national standard development contribution levels is decreasing, with the largest intraregional disparities found in the Northern and Southern Coastal zones. …”
  11. 8771

    Region Division. by Hongjun Sun (12554742)

    Published 2025
    “…The study reveals three key findings. (1) Contribution levels of China’s eight comprehensive economic zones to national standard development have significantly increased. The Northern Coastal comprehensive economic zone has the highest contribution levels, followed by the Eastern and Southern Coastal zones, whereas the Northwestern and Northeastern zones have lower contribution levels. (2) The overall regional disparity in national standard development contribution levels is decreasing, with the largest intraregional disparities found in the Northern and Southern Coastal zones. …”
  12. 8772

    Table 1_A murine model of gestational diabetes reveals MASLD risk and alterations in markers of hepatic mitochondrial metabolism.docx by Grace E. Shryack (21596426)

    Published 2025
    “…</p>Results<p>Progressing gestation in both CD and GDM dams significantly decreased protein and mRNA markers of hepatic mitochondrial biogenesis (Pgc1-α, Tfam), autophagy (Atg5, Sqstm1), mitophagy (Pink1, Bnip3) and lipid handling (Ampk, pAMPK/AMPK, FAS, ACC, pACC, Mttp) with a main effect for time (P<0.05). …”
  13. 8773

    Effectiveness of Interventions to Reduce Sedentary Behaviour in People with Chronic Obstructive Pulmonary Disease: A Systematic Review of Randomised Controlled Trials by Stefanie Harding (21025237)

    Published 2025
    “…Due to the heterogeneity of study design and siting of the activity monitor, a narrative synthesis was conducted.</p> <p>1086 studies were identified; six met inclusion criteria, and two reported a decreased sedentary time. …”
  14. 8774

    Modulating Aesthetic Furniture Preferences through Music: A Multimodal Neurophysiological Study Using Neural Ordinary Differential Equations Networks by Jiufang Lv (20807355)

    Published 2025
    “…</p><p dir="ltr">The findings revealed that musical intervention significantly modulated neural activity in specific frequency bands: prediction error for tactile density in the Alpha band decreased by 26.9%, while prediction accuracy for exquisiteness in the Beta band improved significantly. …”
  15. 8775

    Data_Sheet_1_MakC and MakD are two proteins associated with a tripartite toxin of Vibrio cholerae.pdf by Nandita Bodra (19793703)

    Published 2024
    “…Through deletion mutant analysis, we found that individual deletions of makC or makD do not significantly affect MakA expression or secretion. …”
  16. 8776

    Table 1_Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective.xlsx by Didar Murad (12220805)

    Published 2025
    “…Simulation results highlight key components affected, including thrombin, tissue plasminogen activator, plasmin, fibrin degradation products, interleukin 6 (IL-6), the IL-6 and IL-6R complex, and the terminal complement complex (C5b-9). We explored that the decreased levels of complement factor H and C1-inhibitor significantly elevate these components, whereas tissue factor pathway inhibitor and alpha-2-macroglobulin have more modest effects. …”
  17. 8777

    Table 1_Unravelling the impact of SARS-CoV-2 on hemostatic and complement systems: a systems immunology perspective.xlsx by Didar Murad (12220805)

    Published 2025
    “…Simulation results highlight key components affected, including thrombin, tissue plasminogen activator, plasmin, fibrin degradation products, interleukin 6 (IL-6), the IL-6 and IL-6R complex, and the terminal complement complex (C5b-9). We explored that the decreased levels of complement factor H and C1-inhibitor significantly elevate these components, whereas tissue factor pathway inhibitor and alpha-2-macroglobulin have more modest effects. …”
  18. 8778

    Image 2_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.tiff by Mirjana Askovic (6562304)

    Published 2025
    “…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”
  19. 8779

    Image 1_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.tiff by Mirjana Askovic (6562304)

    Published 2025
    “…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”
  20. 8780

    Table 1_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.pdf by Mirjana Askovic (6562304)

    Published 2025
    “…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”